...Phase III testing for cutaneous T cell lymphoma (CTCL). D. Western Therapeutics Institute Inc. and Wakamoto Pharmaceutical Co. Ltd....

...in Japan (see BioCentury, May 20, 2013). D. Western Therapeutics Institute Inc. (JASDAQ:4576), Nagoyashi, Japan Wakamoto Pharmaceutical Co. Ltd....

...testing is expected to start this year. D. Western Therapeutics Institute Inc. (JASDAQ:4576), Nagoyashi, Japan Wakamoto Pharmaceutical Co. Ltd....